Based on collective observations by us and others in animal models and patients with autoimmune diseases, we hypothesized that CD8 Treg functions can be restored by reducing the inhibitory signals delivered by KIRs, leveraging the selective reduction of pathogenic CD4 T cells, and mitigating the risk of broad immune suppression or off-target toxicities. The gene discussed is CD8A; the disease is autoimmune disease.